The near-flat spread between the 18.96x trailing and 18.78x forward P/E implies the market is capitalizing essentially the current earnings run-rate rather than underwriting acceleration, consistent with the 2.2% revenue growth in the latest print. The larger gap between 16.29x trailing and 12.91x forward EV/EBITDA appears to rest on assumed EBITDA expansion plus continued debt reduction, so investors should treat that step-down as a forecast rather than an observed outcome. The 23.69x P/FCF versus 18.96x P/E divergence also signals that cash conversion has lagged reported earnings over the trailing year, which may temper the appeal of the headline multiple.

With gross margin at 21.1% and operating margin at 11.4%, roughly half of the gross spread is absorbed by SG&A and RDT&E overhead, a ratio that has been the true swing factor rather than pricing itself across the ten-quarter window. The 12.9% free cash flow margin in 2026Q3 versus -18.4% in 2026Q1 suggests reported earnings quality is sound but timing-sensitive, so operating margin adjusted for milestone phasing likely reflects earning power better than any single quarter's net margin of 10.1%. Investors should monitor whether the B-21's move into low-rate initial production holds this operating spread, since a fixed-price tilt could compress margins even if gross margin holds near 21%.

Asset turnover has been essentially flat in a 0.19–0.23 band across all ten quarters, which indicates the modest ROIC improvement is driven by margin recovery rather than any gains in capital efficiency — the goodwill-heavy asset base from the Orbital ATK deal keeps the denominator structurally large. The gap between 3.0% ROIC and 6.1% ROE reflects financial leverage and a shrinking equity base, but ROE itself has eased from 7.0% a year ago as retained earnings compounded equity 31% while buybacks paused. On this trajectory the company appears to be stabilizing rather than compounding returns, and investors should watch whether any ROIC improvement tracks operating margins or simply balance-sheet redeployment.

Coverage at 9.22x versus 8.16x in 2024Q2 suggests interest expense is being carried with rising headroom, and the D/EBITDA reading easing from 14.15 to 10.09 appears consistent with both debt paydown and margin recovery rather than a single lever. Even so, at 0.89 the debt-to-equity ratio remains meaningfully above General Dynamics at 0.38 and RTX at 0.59, so the balance sheet is less defensive than the peer median despite the improvement trend. Refinancing risk looks modest based on these ratios, but with goodwill at roughly one-third of total assets, investors should note that leverage metrics would look materially different under any write-down scenario.

This inversion — best-in-group net margin alongside the weakest ROIC of the profitable primes — appears to reflect an asset base inflated by $17.4B of goodwill and lower capital turns (0.22 versus peers' typically higher turnover), meaning the margin advantage is being diluted across more book assets. The 4.76x P/B versus General Dynamics at 3.73x and Huntington Ingalls at 2.12x suggests the market is paying up for the portfolio rather than for demonstrated returns on capital, a gap that looks structural until Sentinel and B-21 volumes scale. Relative to peers, Northrop also carries less debt than Lockheed Martin (0.89 vs 3.23 D/E) but more than General Dynamics, positioning it in the middle of the group on balance-sheet risk.